Endoscopic sleeve gastroplasty (ESG) induces weight loss through delayed gastric emptying through gastric remodeling.1 In the long term, this commonly manifests as tissue bridges seen on follow-up endoscopy.2,3 ESG’s clinical efficacy, long durability for weight loss,4 and minimal rate of severe adverse events5 have led to widespread adoption. Although “redo” ESG appears safe and effective,6 reversibility is not well described and is limited to the acute setting. There is a risk that cutting sutures acutely may result in microperforations that put a patient at risk for leak, perigastric fluid collection, abscess, and bleeding.